Thompson P J, Gibb W R, Cole P, Citron K M
Thorax. 1984 Aug;39(8):600-3. doi: 10.1136/thx.39.8.600.
Details of three patients who developed allergic responses to aminophylline are presented, together with data on such reactions compiled from reports submitted to the Committee on Safety of Medicines. Two of the patients developed generalised rashes within one day of starting treatment with oral aminophylline. Other symptoms included malaise and confusion. A third patient had severe generalised symptoms and a high fever, which was reproduced on challenge testing. Forty five of 147 reactions to aminophylline reported to the Committee on Safety of Medicines referred to dermatological or allergic reactions and in two instances exfoliative dermatitis was described. In contrast, only seven of 61 reported reactions to theophylline described skin or allergic responses and in none of these was dermatitis or a specified rash mentioned. The available evidence suggests that ethylenediamine rather than the xanthine component of aminophylline may be the principal cause of the reactions.
本文介绍了3例对氨茶碱产生过敏反应的患者的详细情况,以及从提交给药品安全委员会的报告中收集到的有关此类反应的数据。其中2例患者在开始口服氨茶碱治疗1天内出现全身性皮疹。其他症状包括不适和意识模糊。第3例患者出现严重的全身性症状和高热,激发试验再现了这些症状。向药品安全委员会报告的147例氨茶碱反应中,有45例涉及皮肤或过敏反应,其中2例描述为剥脱性皮炎。相比之下,在报告的61例茶碱反应中,只有7例描述了皮肤或过敏反应,且均未提及皮炎或特定皮疹。现有证据表明,氨茶碱反应的主要原因可能是乙二胺而非黄嘌呤成分。